Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Pariente

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Gut|May 31, 2019
Prominence of ileal mucosa-associated microbiota to predict postoperative endoscopic recurrence in Crohn's diseaseHarry Sokol, Loic Brot, Carmen Stefanescu, et al.
Journal of Crohn'S & Colitis|October 6, 2017
Extra-intestinal Manifestations at Diagnosis in Paediatric- and Elderly-onset Ulcerative Colitis are Associated With a More Severe Disease Outcome: A Population-based StudyDana Duricova, Ariane Leroyer, Guillaume Savoye, et al.
Angiology|October 19, 2023
Fluoroquinolone Use Preceding Visceral Artery Dissection: A Case SeriesLouise Z Wang, Boris Oehmichen, Benjamin Pariente, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 7, 2019
Long-term outcome of pediatric-onset Crohn's disease: A population-based cohort studyMathurin Fumery, Benjamin Pariente, Helene Sarter, et al.
Digestive Diseases and Sciences|October 11, 2019
Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn's DiseaseClaire Painchart, Séverine Brabant, Nicolas Duveau, et al.
Inflammatory Bowel Diseases|November 16, 2016
Costs of Crohn's Disease According to Severity States in France: A Prospective Observational Study and Statistical Modeling over 10 YearsGilles Boschetti, Stephane Nancey, Fady Daniel, et al.
United European Gastroenterology Journal|May 5, 2021
Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's diseaseAnthony Buisson, Stéphane Nancey, Luc Manlay, et al.
Alimentary Pharmacology & Therapeutics|August 21, 2018
Male gender, active smoking and previous intestinal resection are risk factors for post-operative endoscopic recurrence in Crohn's disease: results from a prospective cohort studyClaire Auzolle, Stephane Nancey, My-Linh Tran-Minh, et al.
The American Journal of Gastroenterology|July 4, 2020
Postoperative Endoscopic Recurrence on the Neoterminal Ileum But Not on the Anastomosis Is Mainly Driving Long-Term Outcomes in Crohn's DiseaseNassim Hammoudi, Claire Auzolle, My-Linh Tran Minh, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 4, 2018
Dose de-escalation to adalimumab 40 mg every three weeks in patients with inflammatory bowel disease-A multicenter, retrospective, observational studyLieven Pouillon, Anne Lamoureux, Guillaume Pineton de Chambrun, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Gut|May 31, 2019
Prominence of ileal mucosa-associated microbiota to predict postoperative endoscopic recurrence in Crohn's diseaseHarry Sokol, Loic Brot, Carmen Stefanescu, et al.
Journal of Crohn'S & Colitis|October 6, 2017
Extra-intestinal Manifestations at Diagnosis in Paediatric- and Elderly-onset Ulcerative Colitis are Associated With a More Severe Disease Outcome: A Population-based StudyDana Duricova, Ariane Leroyer, Guillaume Savoye, et al.
Angiology|October 19, 2023
Fluoroquinolone Use Preceding Visceral Artery Dissection: A Case SeriesLouise Z Wang, Boris Oehmichen, Benjamin Pariente, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 7, 2019
Long-term outcome of pediatric-onset Crohn's disease: A population-based cohort studyMathurin Fumery, Benjamin Pariente, Helene Sarter, et al.
Digestive Diseases and Sciences|October 11, 2019
Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn's DiseaseClaire Painchart, Séverine Brabant, Nicolas Duveau, et al.
Inflammatory Bowel Diseases|November 16, 2016
Costs of Crohn's Disease According to Severity States in France: A Prospective Observational Study and Statistical Modeling over 10 YearsGilles Boschetti, Stephane Nancey, Fady Daniel, et al.
United European Gastroenterology Journal|May 5, 2021
Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's diseaseAnthony Buisson, Stéphane Nancey, Luc Manlay, et al.
Alimentary Pharmacology & Therapeutics|August 21, 2018
Male gender, active smoking and previous intestinal resection are risk factors for post-operative endoscopic recurrence in Crohn's disease: results from a prospective cohort studyClaire Auzolle, Stephane Nancey, My-Linh Tran-Minh, et al.
The American Journal of Gastroenterology|July 4, 2020
Postoperative Endoscopic Recurrence on the Neoterminal Ileum But Not on the Anastomosis Is Mainly Driving Long-Term Outcomes in Crohn's DiseaseNassim Hammoudi, Claire Auzolle, My-Linh Tran Minh, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 4, 2018
Dose de-escalation to adalimumab 40 mg every three weeks in patients with inflammatory bowel disease-A multicenter, retrospective, observational studyLieven Pouillon, Anne Lamoureux, Guillaume Pineton de Chambrun, et al.
Pageof 9